Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McMaster

Showing results (201-210 of 294) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|March 8, 1997
Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppressionD F Mirza, B K Gunson, Z Soonawalla, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantationG Otto, J Bleyl, P Neuhaus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?J Dmitrewski, S Ayres, B K Gunson, et al.
Transplantation Proceedings|December 1, 1994
Role of total hepatectomy and transplantation in hepatocellular carcinomaA Dalgic, D F Mirza, B K Gunson, et al.
Lancet (London, England)|November 26, 1994
Policies in Europe on "marginal quality" donor liversD F Mirza, B K Gunson, R F Da Silva, et al.
Diabetes|December 1, 1993
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipientsA J Krentz, B Dousset, D Mayer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre studyB Ericzon, C Groth, H Bismuth, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipientsJ Devlin, R Williams, P Neuhaus, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1994
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506A J Krentz, R Cramb, B Dousset, et al.
Transplantation Proceedings|December 1, 1992
HLA matching in liver transplantation: a retrospective analysisB K Gunson, M Hathaway, J A Buckels, et al.
Pageof 30

Showing results (201-210 of 294) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|March 8, 1997
Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppressionD F Mirza, B K Gunson, Z Soonawalla, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantationG Otto, J Bleyl, P Neuhaus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?J Dmitrewski, S Ayres, B K Gunson, et al.
Transplantation Proceedings|December 1, 1994
Role of total hepatectomy and transplantation in hepatocellular carcinomaA Dalgic, D F Mirza, B K Gunson, et al.
Lancet (London, England)|November 26, 1994
Policies in Europe on "marginal quality" donor liversD F Mirza, B K Gunson, R F Da Silva, et al.
Diabetes|December 1, 1993
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipientsA J Krentz, B Dousset, D Mayer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre studyB Ericzon, C Groth, H Bismuth, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipientsJ Devlin, R Williams, P Neuhaus, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1994
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506A J Krentz, R Cramb, B Dousset, et al.
Transplantation Proceedings|December 1, 1992
HLA matching in liver transplantation: a retrospective analysisB K Gunson, M Hathaway, J A Buckels, et al.
Pageof 30